Breath-powered sumatriptan dry nasal powder: an intranasal medication delivery system for acute treatment of migraine.
Ontology highlight
ABSTRACT: There is a need for fast-acting, non-oral medication options for migraine because some attacks develop rapidly and some are accompanied by nausea, vomiting, and gastroparesis, which can hinder oral medication uptake and absorption. The most commonly prescribed migraine medications are oral triptans, with sumatriptan as the most common. However, oral triptans are associated with adverse events (AEs) of atypical sensations that may be problematic for patients. Subcutaneous (SC) injectable sumatriptan and conventional liquid triptan nasal spray formulations are also available, but the frequency of atypical sensations is the highest with SC sumatriptan, and the intense bitter taste of conventional liquid triptan nasal spray discourages use. AVP-825 (ONZETRA® Xsail®) is an intranasal medication
SUBMITTER: Tepper SJ
PROVIDER: S-EPMC5937501 | biostudies-literature | 2018
REPOSITORIES: biostudies-literature
ACCESS DATA